Travis Osterman, DO, MS, assistant professor of Biomedical Informatics (DBMI), Hematology and Oncology and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been appointed to a new role as Associate Vice President for Research Informatics at Vanderbilt University Medical Center.
Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.
The Oscar-winning and Grammy-winning international cinema and music superstars have been longtime cancer research supporters. They live in Nashville, home of Vanderbilt-Ingram, which has internationally recognized breast cancer researchers and clinicians.
Cathy Eng, MD, the David H. Johnson Professor of Surgical and Medical Oncology, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum on Friday, March 10.
Vanderbilt-Ingram Cancer Center is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.
Kimryn Rathmell, MD, PhD, MMHC, chair of the Department of Medicine at Vanderbilt University Medical Center, is one of four Vanderbilt University faculty members elected this year to the American Academy of Arts & Sciences.
A liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers, according to data from a retrospective study presented at the AACR Annual Meeting 2023, held recently in Orlando, Florida.
Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical
Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer. The study, published recently in Cancer Discovery, reveals cues toward the development of personalized treatment approaches.
